Yuan, Zuohui
Yang, Xiaoping
Wang, Xiaochun
Shi, Xinlong
Chen, Jia
Huang, Lijun
Yang, Jie
Shi, Yuping
Zhang, Liping
Mai, Ping
Funding for this research was provided by:
Lanzhou Science and Technology Bureau (NO. 2022-3-1, NO. 2022-3-1, NO. 2022-3-1, NO. 2022-3-1, NO. 2022-3-1, NO. 2022-3-1, NO. 2022-3-1, NO. 2022-3-1, NO. 2022-3-1, NO. 2022-3-1)
Natural Science Foundation of Gansu Province (NO. 23JRRA1769, NO. 23JRRA1769, NO. 23JRRA1769, NO. 23JRRA1769, NO. 23JRRA1769, NO. 23JRRA1769, NO. 23JRRA1769, NO. 23JRRA1769, NO. 23JRRA1769, NO. 23JRRA1769)
Article History
Received: 1 March 2025
Accepted: 28 July 2025
First Online: 9 October 2025
Declarations
:
: This study is approved by the Medical Ethics Committee of Gansu Provincial Hospital (Protocol No. 2022-057) and Animal Experimental Ethical Inspection of Gansu University of Chinese Medicine (No. 2023 − 368).
: Not applicable.
: The authors declare no competing interests.
: We confirm that there are no financial or professional relationships with any melatonin manufacturers or related commercial entities, and thus no conflicts of interest arising from such ties.